Not checked for notices yet.
Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
Mohammad Reza Hatamnejad, Shaghayegh Baradaran Ghavami, Marzieh Shirvani and 6 more
Frontiers in Immunology · 2022
Cited by papers we hold 1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.